Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine Add-on vs Monotherapy in Bipolar II Depression
NCT00475137Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Dec 2007
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of lamotrigine in Bipolar II disorder (BP-II) (2 arms), sponsored by University of British Columbia. Primary endpoint: Montgomery-Asberg Depression Rating Scale at 8 weeks. Started Dec 2007; status: completed.
02
Drugs
lamotrigine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00475137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475137.